North America Leads the Glaucoma Therapeutics Market Amid Rising Prevalence
North America has established itself as the dominant region in the global Glaucoma Therapeutics Market, driven by advanced healthcare infrastructure, high awareness of eye diseases, and significant investment in ophthalmic research. The region accounted for a substantial share in 2024 and is expected to maintain its leadership through 2035. The Glaucoma Therapeutics Market in North America...
0 Yorumlar 0 hisse senetleri 57 Views 0 önizleme